SE9302278D0 - Growth hormone - Google Patents
Growth hormoneInfo
- Publication number
- SE9302278D0 SE9302278D0 SE19939302278A SE9302278A SE9302278D0 SE 9302278 D0 SE9302278 D0 SE 9302278D0 SE 19939302278 A SE19939302278 A SE 19939302278A SE 9302278 A SE9302278 A SE 9302278A SE 9302278 D0 SE9302278 D0 SE 9302278D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- date
- alkyl
- crystals
- growth hormone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939302278A SE9302278D0 (sv) | 1992-10-28 | 1993-07-02 | Growth hormone |
EP93924266A EP0669934B1 (en) | 1992-10-28 | 1993-10-27 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
ES93924266T ES2126660T3 (es) | 1992-10-28 | 1993-10-27 | Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos. |
DE69322654T DE69322654T2 (de) | 1992-10-28 | 1993-10-27 | Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle |
JP51096494A JP3470135B2 (ja) | 1992-10-28 | 1993-10-27 | 成長ホルモンの結晶体を製造する方法およびそれにより得られる結晶体 |
DK93924266T DK0669934T3 (da) | 1992-10-28 | 1993-10-27 | Fremgangsmåde til fremstilling af krystaller af væksthormon og derved opnåede krystaller |
CA002147482A CA2147482C (en) | 1992-10-28 | 1993-10-27 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
PCT/SE1993/000885 WO1994010192A1 (en) | 1992-10-28 | 1993-10-27 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
US08/424,450 US5734026A (en) | 1992-10-28 | 1993-10-27 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
AU54011/94A AU679012B2 (en) | 1992-10-28 | 1993-10-27 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
AT93924266T ATE174602T1 (de) | 1992-10-28 | 1993-10-27 | Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle |
NO19951547A NO320171B1 (no) | 1992-10-28 | 1995-04-24 | Fremgangsmate for fremstilling av krystaller av veksthormon eller funksjonelle derivater derav, krystaller fremstilt ved fremgangsmaten, anvendelse av kjemisk forbindelse for fremstilling av krystallene, suspensjon for injeksjon, torrformulering og depotformulering som omfatter krystallene, anvendelse av krystallene for fremstilling av medikament og fremgangsmate for rensing av veksthormon. |
FI952021A FI110609B (sv) | 1992-10-28 | 1995-04-27 | Förfarande för framställning av tillväxthormonkristaller |
HK98114660A HK1013299A1 (en) | 1992-10-28 | 1998-12-22 | Process for manufacturing crystals of growth hormone and crystals thereby obtained |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9203175A SE9203175D0 (sv) | 1992-10-28 | 1992-10-28 | Growth hormone |
SE19939302278A SE9302278D0 (sv) | 1992-10-28 | 1993-07-02 | Growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9302278D0 true SE9302278D0 (sv) | 1993-07-02 |
Family
ID=26661557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE19939302278A SE9302278D0 (sv) | 1992-10-28 | 1993-07-02 | Growth hormone |
Country Status (14)
Country | Link |
---|---|
US (1) | US5734026A (sv) |
EP (1) | EP0669934B1 (sv) |
JP (1) | JP3470135B2 (sv) |
AT (1) | ATE174602T1 (sv) |
AU (1) | AU679012B2 (sv) |
CA (1) | CA2147482C (sv) |
DE (1) | DE69322654T2 (sv) |
DK (1) | DK0669934T3 (sv) |
ES (1) | ES2126660T3 (sv) |
FI (1) | FI110609B (sv) |
HK (1) | HK1013299A1 (sv) |
NO (1) | NO320171B1 (sv) |
SE (1) | SE9302278D0 (sv) |
WO (1) | WO1994010192A1 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9302278D0 (sv) * | 1992-10-28 | 1993-07-02 | Kabi Pharmacia Ab | Growth hormone |
US6500933B1 (en) | 1997-09-05 | 2002-12-31 | Altus Biologics Inc. | Methods of preparing carbohydrate crosslinked glycoprotein crystals |
WO1999012959A1 (en) | 1997-09-05 | 1999-03-18 | Altus Biologics Inc. | Carbohydrate crosslinked glycoprotein crystals |
US6380357B2 (en) * | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
US6541606B2 (en) * | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
US20050148497A1 (en) * | 2002-02-20 | 2005-07-07 | Khan Mohammed A. | Method for administering glp-1 molecules |
SE0202719D0 (sv) * | 2002-09-13 | 2002-09-13 | Pharmacia Ab | Process for mfg crystals of growth hormone |
KR20050090430A (ko) * | 2002-12-31 | 2005-09-13 | 알투스 파마슈티컬스 인코포레이티드 | 인간 성장 호르몬 결정 및 이것의 제조 방법 |
US20060286129A1 (en) * | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
US7444197B2 (en) | 2004-05-06 | 2008-10-28 | Smp Logic Systems Llc | Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes |
US7799273B2 (en) | 2004-05-06 | 2010-09-21 | Smp Logic Systems Llc | Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes |
WO2007076131A2 (en) * | 2005-12-23 | 2007-07-05 | Altus Pharmaceuticals Inc. | Compositions comprising polycation-complexed protein crystals and methods of treatment using them |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE149523T1 (de) * | 1990-06-04 | 1997-03-15 | Schering Corp | Verfahren zur herstellung von interferon-alpha-2 kristallen |
PL166951B1 (pl) * | 1990-06-15 | 1995-07-31 | Schering Corp | Sposób wytwarzania tetragonalnych krysztalów ludzkiej interleukiny-4 PL PL PL PL |
DK168790D0 (sv) * | 1990-07-13 | 1990-07-13 | Novo Nordisk As | |
US5015627A (en) * | 1990-07-20 | 1991-05-14 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
SE9302278D0 (sv) * | 1992-10-28 | 1993-07-02 | Kabi Pharmacia Ab | Growth hormone |
-
1993
- 1993-07-02 SE SE19939302278A patent/SE9302278D0/sv unknown
- 1993-10-27 WO PCT/SE1993/000885 patent/WO1994010192A1/en active IP Right Grant
- 1993-10-27 US US08/424,450 patent/US5734026A/en not_active Expired - Fee Related
- 1993-10-27 AT AT93924266T patent/ATE174602T1/de not_active IP Right Cessation
- 1993-10-27 DE DE69322654T patent/DE69322654T2/de not_active Expired - Fee Related
- 1993-10-27 CA CA002147482A patent/CA2147482C/en not_active Expired - Fee Related
- 1993-10-27 DK DK93924266T patent/DK0669934T3/da active
- 1993-10-27 EP EP93924266A patent/EP0669934B1/en not_active Expired - Lifetime
- 1993-10-27 AU AU54011/94A patent/AU679012B2/en not_active Ceased
- 1993-10-27 JP JP51096494A patent/JP3470135B2/ja not_active Expired - Fee Related
- 1993-10-27 ES ES93924266T patent/ES2126660T3/es not_active Expired - Lifetime
-
1995
- 1995-04-24 NO NO19951547A patent/NO320171B1/no unknown
- 1995-04-27 FI FI952021A patent/FI110609B/sv active
-
1998
- 1998-12-22 HK HK98114660A patent/HK1013299A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2126660T3 (es) | 1999-04-01 |
DK0669934T3 (da) | 1999-08-23 |
CA2147482A1 (en) | 1994-05-11 |
HK1013299A1 (en) | 1999-08-20 |
ATE174602T1 (de) | 1999-01-15 |
NO951547L (no) | 1995-04-24 |
EP0669934A1 (en) | 1995-09-06 |
NO951547D0 (no) | 1995-04-24 |
NO320171B1 (no) | 2005-11-07 |
AU5401194A (en) | 1994-05-24 |
JPH08505127A (ja) | 1996-06-04 |
FI952021A (sv) | 1995-04-27 |
US5734026A (en) | 1998-03-31 |
DE69322654D1 (de) | 1999-01-28 |
DE69322654T2 (de) | 1999-06-17 |
AU679012B2 (en) | 1997-06-19 |
CA2147482C (en) | 2003-09-23 |
EP0669934B1 (en) | 1998-12-16 |
FI110609B (sv) | 2003-02-28 |
WO1994010192A1 (en) | 1994-05-11 |
FI952021A0 (sv) | 1995-04-27 |
JP3470135B2 (ja) | 2003-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9302278D0 (sv) | Growth hormone | |
KR860002958A (ko) | 살균제의 제법 | |
DE69503604D1 (de) | Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung | |
ATE163418T1 (de) | Risperidon pamoate | |
JPS6425763A (en) | Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient | |
HUT36784A (en) | Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents | |
TR199901055T2 (xx) | Benzimidazol t�revlerinin kristalleri ve bunlar�n �retimi. | |
FI911411A0 (sv) | Kristallin, kristallvattenfri laktitol och förfarande för dess framställning samt användning därav | |
ES8802421A1 (es) | Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico | |
FI98510B (sv) | Vaterit och förfarande för dess framställning | |
YU46699B (sh) | Kristalni monohidratni oblik 1-karbacefalosporina | |
IT1243801B (it) | Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione | |
ES2043070T3 (es) | Procedimiento para la preparacion de derivados de la benzotiazolamina-2. | |
ES2118256T3 (es) | Derivados de acido propenoico utiles como fungicidas. | |
DE69614841D1 (de) | Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion | |
ATE34661T1 (de) | Verbindungen zur verminderung des lipidspiegels. | |
DE69232980D1 (de) | Pyrroloazepinderivate | |
UA66832C2 (uk) | Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція |